08/20/2014
The use of opioid painkillers in the United States has been called an epidemic by the Centers for Disease Control, yet as we look at treatment options for pain patients, we may wrongly assume that non-opioid painkillers are safer, cheaper or more effective.
In this webinar, experts with more than 20 years of experience treating pain conditions review the most prescribed non-opioid painkillers, including Lidoderm, Flector, and Cymbalta, lifting the curtain on the significant impact these drugs can have on patients’ lives and an insurance carrier’s bottom line, while providing a path forward to evidence-based decision making.
Join Hassan Moinzadeh, MD, an associate professor at University of California, Irvine and physician at Long Beach Memorial Medical Center, and Steven Moskowitz, MD, senior medical director of Paradigm’s pain program, as they discuss how to target and achieve the best outcomes for your pain claimants with the confidence of an evidence-based approach to available treatments.
